Vi er interessert i forskningsspørsmål som ligger på grensesnittet mellom kjemi og biologi. Forskningsprosjektene vi er involvert i er forankret i legemiddelkjemi og biologisk kjemi, og vi bruker syntetisk organisk kjemi som metode for å addressere våre forskningsspørsmål. Gruppen har hatt en viktig rolle i etableringen av Laboratory for high-throughput experimentation - HTE@UiB, og den nasjonale infrastrukturen Norwegian Open Laboratory for High-Throughput Experimentation and Scale-Up (NorHTE) som professor Haug leder. Flere av prosjektene vi jobber med krever også tilgang til syntetiske peptider, og gruppen har etablert og driver Laboratorium for peptidsyntese ved Kjemisk institutt.

Se gruppens nettsider for mer informasjon.

Vitenskapelig artikkel

• Martin Paul Heimböck; Kine Østnes Hansen; Yngve Guttormsen et al. (2026). Inhibition of Staphylococcus epidermidis Biofilm Formation by a Synthetic Breitfussin Analogue. (ekstern lenke)
• Ida Amalie Nystad Reierth; Yngve Guttormsen; Jeanette Hammer Andersen et al. (2025). Investigation of the histone deacetylase inhibitor potential of phorbazole analogues. (ekstern lenke)
• Vipul Navinchandra Panchal; Jan-Åke Husmann; Kaja Günther et al. (2025). Discovery of RNA-binding fragments using biolayer interferometry. (ekstern lenke)
• Shailesh Narawane; Adnan Budnjo; Cédric Grauffel et al. (2014). In silico design, synthesis, and assays of specific substrates for proteinase 3: Influence of fluorogenic and charged groups. (ekstern lenke)
• Liwei Liu; Adnan Budnjo; Jouni Jokela et al. (2015). Pseudoaeruginosins, nonribosomal peptides in nodularia spumigena. (ekstern lenke)
• Elvira García de Jalón; Katrin Kleinmanns; Vibeke Samuelsen Fosse et al. (2021). Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model. (ekstern lenke)
• Zack Georg Zachariassen; Stefanie Karlshøj; Bengt Erik Haug et al. (2015). Probing the molecular interactions between CXC chemokine receptor 4 (CXCR4) and an arginine-based tripeptidomimetic antagonist (KRH-1636). (ekstern lenke)
• Bengt Erik Haug; Ketil Andre Camilio; liv tone Eliassen et al. (2016). Discovery of a 9-mer cationic peptide (LTX-315) as a potential first in class oncolytic peptide. (ekstern lenke)
• Signe Steinkopf; Linda Hanekam; Marit Schaathun et al. (2012). Interaction of local anaesthetic articaine enantiomers with brain lipids: A Langmuir monolayer study. (ekstern lenke)
• Charis Georgiou; Ludvik Olai Espeland; Hemalatha Bukya et al. (2025). Towards new antibiotics: P. aeruginosa FabF ligands discovered by crystallographic fragment screening followed by hit expansion. (ekstern lenke)
• Johan Karl Svenson; Wenche Stensen; Bjørn Olav Brandsdal et al. (2008). Antimicrobial Peptides with Stability toward Tryptic Degradation. (ekstern lenke)
• Bengt Erik Haug; Wenche Stensen; John Sigurd Svendsen (2007). Application of the Suzuki-Miyaura cross-coupling to increase antimicrobial potency generates promising novel antibacterials. (ekstern lenke)
• Janne M. Nestvold; Mengyu Wang; Ketil Andre Camilio et al. (2017). Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model. (ekstern lenke)
• Line Merethe Myklebust; Markus Baumann; Svein Isungset Støve et al. (2023). Optimized bisubstrate inhibitors for the actin N-terminal acetyltransferase NAA80. (ekstern lenke)
• Oscar Aubi Catevilla; Marte Innselset Flydal; Huaixin Zheng et al. (2015). Discovery of a Specific Inhibitor of Pyomelanin Synthesis in Legionella pneumophila. (ekstern lenke)
• Kine Østnes Hansen; Jeanette hammer Andersen; Annette Bayer et al. (2019). Kinase chemodiversity from the Arctic: the breitfussins. (ekstern lenke)
• Yngve Guttormsen; Magnus John Espeland Fairhurst; Sunil Kumar Pandey et al. (2020). Total synthesis of phorbazole B. (ekstern lenke)
• Tahir Farooq; Leiv Kristen Sydnes; Karl Wilhelm Törnroos et al. (2012). Debenzylation of Functionalized 4-and 5-substituted 1,2,3-fTriazoles. (ekstern lenke)
• Svein Isungset Støve; Robert S. Magin; Håvard Foyn et al. (2016). Crystal structure of the Golgi-associated human N-alpha acetyltransferase 60 (Naa60/NatF) reveals the molecular determinants for substrate-specific acetylation.. (ekstern lenke)
• Bengt Erik Haug; Wenche Stensen; manar Kalaaji et al. (2008). Synthetic antimicrobial peptidomimetics with therapeutic potential. (ekstern lenke)
• Baldur Sveinbjørnsson; Ketil Andre Camilio; Bengt Erik Haug et al. (2017). LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment. (ekstern lenke)
• Markus Baumann; Lina Marie Nome; Zack Georg Zachariassen et al. (2017). Synthesis of a novel tripeptidomimetic scaffold and biological evaluation for CXC chemokine receptor 4 (CXCR4) antagonism. (ekstern lenke)
• Fahimeh Khorsand; Bengt Erik Haug; Inari Talvikki Kursula et al. (2024). Expression and purification of human neutrophil proteinase 3 from insect cells and characterization of ligand binding. (ekstern lenke)
• Sebastian Berge-Seidl; Nis Valentin Nielsen; Armando A. Rodriguez Alfonso et al. (2022). Identification of a phage display-derived peptide interacting with the N-terminal region of factor VII activating protease (FSAP) enables characterization of zymogen activation. (ekstern lenke)
• Rianne Harmsen; Leiv Kristen Sydnes; Karl Wilhelm Törnroos et al. (2011). Synthesis of trans-4-Triazolyl-Substituted 3-Hydroxypiperidines. (ekstern lenke)
• Åge Aleksander Skjevik; Bengt Erik Haug; Henning Lygre et al. (2011). Intramolecular hydrogen bonding in articaine can be related to superior bone tissue penetration: A molecular dynamics study. (ekstern lenke)
• Gorka Ruiz de Garibay; Elvira García de Jalón; Endre Stigen et al. (2021). Repurposing 18F-FMISO as a PET tracer for translational imaging of nitroreductase-based gene directed enzyme prodrug therapy. (ekstern lenke)
• Adnan Budnjo; Shailesh Narawane; Cédric Grauffel et al. (2014). Reversible ketomethylene-based inhibitors of human neutrophil proteinase 3. (ekstern lenke)
• Marianne Goris; Robert S. Magin; Håvard Foyn et al. (2018). Structural determinants and cellular environment define processed actin as the sole substrate of the N-terminal acetyltransferase NAA80. (ekstern lenke)
• Bengt Erik Haug; Merete L. Skar; John Sigurd Svendsen (2001). Bulky Aromatic Amino Acids Increase the Antibacterial Activity of Bovine Lactoferricin Peptides. (ekstern lenke)
• Bengt Erik Haug; John Sigurd Svendsen (2001). The Role of Tryptophan in the Antibacterial Activity of a 15-Residue Bovine Lactoferricin Peptide. (ekstern lenke)
• Ikenna E. Ndukwe; Yu-hong Lam; Sunil Kumar Pandey et al. (2020). Unequivocal structure confirmation of a breitfussin analog by anisotropic NMR measurements. (ekstern lenke)
• Zack Georg Zachariassen; Stefanie Thiele; Erik Berg et al. (2014). Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4). (ekstern lenke)
• Tore Sigvard Lejon; Bengt Erik Haug (2000). Fargestoffer i Sopp. (ekstern lenke)
• M. B. Strøm; Bengt Erik Haug; Øystein Rekdal et al. (2001). Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. (ekstern lenke)
• Bengt Erik Haug; Merete L. Skar; John Sigurd Svendsen (2001). The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin. (ekstern lenke)
• Bengt Erik Haug; Jill Mari Andersen; Øystein Rekdal et al. (2002). Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc). (ekstern lenke)
• Tore Lejon; John Sigurd Svendsen; Bengt Erik Haug (2002). Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides. (ekstern lenke)
• Magnus John E. Fairhurst; Zeeshan Muhammad; Bengt Erik Haug et al. (2018). Aldol condensations on a 3-alkylidene-2,5-diketopiperazine - synthesis of two marine natural products. (ekstern lenke)
• Sunil Kumar Pandey; Yngve Guttormsen; Bengt Erik Haug et al. (2015). A concise total synthesis of breitfussin A and B. (ekstern lenke)
• Elvira García de Jalón; Gorka Ruiz de Garibay; Bengt Erik Haug et al. (2021). CytoCy5S™, a compound of many structures. in vitro and in vivo evaluation of four near-infrared fluorescent substrates of nitroreductase (NTR). (ekstern lenke)
• Parveen Gartan; Fahimeh Khorsand; Pushpak Mizar et al. (2024). Investigating Polypharmacology through Targeting Known Human Neutrophil Elastase Inhibitors to Proteinase 3. (ekstern lenke)
• Bengt Erik Haug; M Brewer; DH Rich (2005). Facile degradative lactonization of Gln-Arg and Gln-Phe hydroxyethylene dipeptide derivatives. (ekstern lenke)
• Bengt Erik Haug; Wenche Stensen; Trine Stiberg et al. (2004). Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. (ekstern lenke)
• Rianne Harmsen; Annfrid Sivertsen; Davide Michetti et al. (2013). Synthesis and docking of novel piperidine renin inhibitors. (ekstern lenke)
• Ludvik Olai Espeland; Charis Georgiou; Raphael Klein et al. (2021). An Experimental Toolbox for Structure-Based Hit Discovery for P. aeruginosa FabF, a Promising Target for Antibiotics. (ekstern lenke)
• M. B. Strøm; Bengt Erik Haug; Merete L. Skar et al. (2003). The Pharmacophore of Short Cationic Antibacterial Peptides. (ekstern lenke)
• Nicolai Etwin Alsaker; Øyvind Halskau; Bengt Erik Haug et al. (2024). Phospholipid Membrane Interactions of Model Ac-WL-X-LL-OH Peptides Investigated by Solid-State Nuclear Magnetic Resonance. (ekstern lenke)
• Markus Baumann; Mohammad Musarraf Hussain; Nina Henne et al. (2017). Influence of chain length on the activity of tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4). (ekstern lenke)
• liv tone Eliassen; Bengt Erik Haug; Gerd Berge et al. (2003). Enhanced antitumor activity of 15-residue bovine lactoferricin derivatives containing bulky aromatic amino acids and lipophilic N-terminal modifications. (ekstern lenke)
• Emmet McCormack; Elisabeth Silden; Richard M. West et al. (2013). Nitroreductase, a near-infrared reporter platform for in vivo time-domain optical imaging of metastatic cancer. (ekstern lenke)
• Bengt Erik Haug; Daniel H. Rich (2004). Synthesis of a Gln-Phe hydroxyethylene dipeptide isostere. (ekstern lenke)
• Tahir Farooq; Bengt Erik Haug; Leiv Kristen Sydnes et al. (2012). 1,3-Dipolar cycloaddition of benzyl azide to two highly functionalized alkynes. (ekstern lenke)
• Øystein Rekdal; Bengt Erik Haug; manar Kalaaji et al. (2012). The relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determines their cytotoxicity. (ekstern lenke)

Annen presentasjon

• Bengt Erik Haug (2026). Hvordan oppdages nye medisiner?. (ekstern lenke)
• Bengt Erik Haug (2026). NorHTE - en nasjonal infrastruktur for robotisert kjemi. (ekstern lenke)
• Bengt Erik Haug (2025). Morgendagens kjemilaboratorium. (ekstern lenke)

Konferanseforedrag

• Bengt Erik Haug (2025). Norwegian Open Laboratory forHigh-Throughput Experimentation and Scale-up NorHTE. (ekstern lenke)
• Bengt Erik Haug (2025). Norwegian open infrastructure for high-throughput experimentation and scale-up (NorHTE)- Plans and opportunities. (ekstern lenke)
• Parveen Gartan; Fahimeh Khorsand; Pushpak Mizar et al. (2024). Investigating polypharmacology through targeting known human neutrophil elastase inhibitors to proteinase 3. (ekstern lenke)
• Ruth Brenk; Bengt Erik Haug; Charis Georgiou (2022). TARGETING A PSEUDOMONAS AERUGINOSA β-KETOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE WITH COVALENT INHIBITORS INSPIRED BY CERULENIN. (ekstern lenke)
• Bengt Erik Haug; John Sigurd Svendsen (2000). Increased Antibacterial activity of 15-residues Bovine Lactoferricin Derivatives employing non-coded Aromatic Amino Acids,. (ekstern lenke)
• Bengt Erik Haug; John Sigurd Svendsen (2001). Antibacterial Activity of 15-Residues Bovine Lactoferricin Derivatives Employing non-coded Aromatic Amino Acids, Peptides 2000. (ekstern lenke)
• Sunil Kumar Pandey; Yngve Guttormsen; Bengt Erik Haug et al. (2015). Total synthesis of breitfussin A and B.. (ekstern lenke)
• Bengt Erik Haug (2012). Synthesis of piperidine derivatives. (ekstern lenke)
• Bengt Erik Haug (2009). Synthesis of biologically active peptides and peptidomimetics. (ekstern lenke)
• Bengt Erik Haug (2020). Synthesis and Biological Activity of the Breitfussins. (ekstern lenke)
• Nicolai Etwin Alsaker; Willy Nerdal; Bengt Erik Haug et al. (2023). Phospholipid membrane interactions of model peptides and depth of insertion investigated via solid-state NMR. (ekstern lenke)
• Ruth Brenk; Bengt Erik Haug; Jarl Underhaug et al. (2021). Targeting Bacterial Fatty Acid Synthesis using Fragment-Based Drug Design. (ekstern lenke)
• Bengt Erik Haug (2012). Hvordan lager man et legemiddel?. (ekstern lenke)
• Stian Hersvik Hegdahl; Kristine Akervold; Usanee Kongjampee et al. (2022). Biogas Residues as Feedstock for Hydrothermal Conversion: Bio-Oil Yield Optimisation and Fate of Drugs. (ekstern lenke)
• Tahir Farooq; Bengt Erik Haug; Leiv Kristen Sydnes (2010). [3+2] Cycloaddition of benzyl azide to two highly functionalized alkynes. (ekstern lenke)
• Michel Herranz Carnero; Angel Moldes-Anaya; Bengt Erik Haug et al. (2022). Innovative molecular imaging technique for Granzyme-B characterization as an emerging biomarker for radio-immunotherapy combinations. (ekstern lenke)
• Bengt Erik Haug (2006). Synthesis of a Gln-Phe hydroxyethylene dipeptide isostere. (ekstern lenke)
• Bengt Erik Haug (2016). Discovery of LTX-315 - A potential first-in-class oncolytic peptide. (ekstern lenke)
• Guillaume Petit; Kine Østnes Hansen; Jeanette Hammer Andersen et al. (2023). A fragment to bind them all: Characterising phorbazole fragments as pan-kinase inhibitor. (ekstern lenke)
• Bengt Erik Haug (2014). Design and synthesis of ketomethylene-based inhibitors of human neutrophil Proteinase 3. (ekstern lenke)
• Bengt Erik Haug (2014). Design and synthesis of substrates and inhibitors for Proteinase 3. (ekstern lenke)
• Bengt Erik Haug (2012). Novel Renin Inhibitors. (ekstern lenke)
• Bengt Erik Haug (2016). BIOSNet - From marine natural products to commercial leads. (ekstern lenke)

Forelesning

• Bengt Erik Haug (2025). How to build up an interdiciplinary research environment and large infrastructures over time?. (ekstern lenke)
• Bengt Erik Haug (2024). Design and synthesis of novel ligandsfor protein and RNA targets for new antibiotics. (ekstern lenke)
• Bengt Erik Haug (2024). Legemiddelutvikling og antibiotika. (ekstern lenke)
• Bengt Erik Haug (2012). Hvordan lager man et legemiddel?. (ekstern lenke)
• Bengt Erik Haug (2013). Hvordan lager man legemiddelmolekyler?. (ekstern lenke)
• Bengt Erik Haug (2012). The Nobel Prize in Chemistry 2012. (ekstern lenke)
• Bengt Erik Haug (2014). Havet - vårt nye medisinskap?. (ekstern lenke)
• Bengt Erik Haug (2007). Antimikrobielle peptider - En kilde til utvikling av fremtidenslegemidler mot mikrober og kreft?. (ekstern lenke)
• Bengt Erik Haug (2012). Peptider og legemiddelutvikling. (ekstern lenke)
• Bengt Erik Haug (2016). Peptider, peptidomimetika og legemiddelutvikling. (ekstern lenke)

Fagartikkel

• Bengt Erik Haug; John Christian de Mello (2025). Ny nasjonal infrastruktur for robotisert kjemi. (ekstern lenke)

Konferanseposter

• Signe Lilia Steinkopf; Linda Hanekam; Marit Schaathun et al. (2012). Local Anestethic Articaine Enantiomers interaction with Brain Lipids.. (ekstern lenke)
• Carlos Fabio Magalhaes da Silva; Jan-Åke Husmann; Vipul Navinchandra Panchal et al. (2025). Enlarging the Scaffold Space for the development of novel potential FMN riboswitch ligands. (ekstern lenke)
• Carlos Fabio Magalhaes da Silva; Jan-Åke Husmann; Vipul Navinchandra Panchal et al. (2025). Enlarging the Scaffold Space for the development of novel potential FMN riboswitch ligands. (ekstern lenke)
• Carlos Fabio Magalhaes da Silva; Muhammad Zeeshan; Jan-Åke Husmann et al. (2025). From a lead to a fragment hit: Dissecting ribocil, a drug-like RNA ligand. (ekstern lenke)
• Parveen Gartan; Fahimeh Khorsand; Pushpak Mizar et al. (2022). Potential dual-inhibitors of human neutrophil elastase and proteinase 3: drug targets for COPD. (ekstern lenke)
• Lisa Haarer; Ruth Brenk; Bengt Erik Haug (2025). Development of new potential ligands targeting P. aeruginosa FabF using a fragment-based approach. (ekstern lenke)
• Rianne Harmsen; Annfrid Sivertsen; Davide Michetti et al. (2012). Synthesis and docking of 4-triazolyl substituted piperidine derivatives as novel renin inhibitors. (ekstern lenke)
• Rasmus Moen Ree; Line Merethe Myklebust; Håvard Foyn et al. (2018). naa10 knockdown and NatA inhibition point to role for the NatA complex in zebrafish dorsoventral axis formation. (ekstern lenke)
• Markus Baumann; Jon Våbenø; Bengt Erik Haug (2015). Synthetic studies towards peptidomimetic CXCR4 antagonists. (ekstern lenke)
• Markus Baumann; Jon Våbenø; Bengt Erik Haug (2014). Synthetic studies towards CXCR4 antagonists. (ekstern lenke)
• Tahir Farooq; Bengt Erik Haug; Leiv K. Sydnes (2009). Cycloaddition with highly functionalized terminal alkynes. (ekstern lenke)
• Ruth Brenk; Bengt Erik Haug; Charis Georgiou (2022). A P. AERUGINOSA FATTY ACID SYNTHESIS PROTEIN CRYSTALLOGRAPHIC FRAGMENT SCREEN AND ATTEMPTED OPTIMIZATION OF A HIT. (ekstern lenke)
• Adnan Budnjo; Bengt Erik Haug (2012). Synthesis of a Ketomethylene Dipeptide Isostere. (ekstern lenke)
• Illimar Rekand; Muhammad Zeeshan; Pushpak Mizar et al. (2022). Structure-based hit discovery for riboswitch ligands. (ekstern lenke)
• Rianne Harmsen; Leiv Kristen Sydnes; Karl Wilhelm Törnroos et al. (2011). Synthesis of 3,4-disubstituted piperidines. (ekstern lenke)
• Markus Baumann; Line Merethe Myklebust; Marianne Goris et al. (2018). Inhibition of the Actin N-terminal acetyltransferase NAA80. (ekstern lenke)
• Yngve Guttormsen; Sunil Kumar Pandey; Bengt Erik Haug et al. (2017). Halogenation of electron rich heterocycles: Where does it go?. (ekstern lenke)
• Signe Steinkopf; Linda Hanekam; Marit Schaathun et al. (2012). Local Anesthetic Articaine Enantiomers interaction with Brain Lipids. (ekstern lenke)
• Bengt Erik Haug (2006). Novel Antibacterial Tripeptides. (ekstern lenke)
• Magnus John E. Fairhurst; Muhammad Zeeshan; Annette Bayer et al. (2017). Synthesis of the natural product (3Z,6Z)-3-((1H-imidazol-5-yl)methylene)-6-(2-methylpropylidene)-piperazine-2,5-dione. (ekstern lenke)
• Bengt Erik Haug; John Sigurd Svendsen (2001). Preparation of (2S)-3-amino-(2,2,5,7,8-pentamethyl-chroman-6-sulfonyl)-1H-indol-3-yl)-propionic acid and its incorporation into antibacterial lactoferricin peptides. (ekstern lenke)
• Sunil Kumar Pandey; Yngve Guttormsen; Bengt Erik Haug et al. (2016). Total Synthesis of Breitfussin A and B. (ekstern lenke)
• Nina Henne; Jon Våbenø; Bengt Erik Haug (2014). Synthetic studies towards CXCR4 antagonists. (ekstern lenke)
• Markus Baumann; Jon Våbenø; Bengt Erik Haug (2015). Synthetic studies towards CXCR4 antagonists. (ekstern lenke)
• Bengt Erik Haug; Markus Baumann; Karlshøj Stefanie et al. (2016). Scaffold-based tripeptidomimetic CXCR4 antagonists. (ekstern lenke)
• Illimar Hugo Rekand; Bengt Erik Haug (2016). Synthesis of a Challenging Amide. (ekstern lenke)
• Adnan Budnjo; Shailesh Narawane; Nathalie Reuter et al. (2014). Synthesis and biological evaluation of pseudopeptide inhibitors of Proteinase 3. (ekstern lenke)
• Elvira Garcia de Jalón; Kjetil Børve Lund; Endre Stigen et al. (2015). Synthetic studies towards nitroreductase-activated fluorescent probes. (ekstern lenke)
• Markus Baumann; Line Merethe Myklebust; Håvard Foyn et al. (2020). Inhibition of the Actin N-terminal acetyltransferase NAA80. (ekstern lenke)
• Magnus John E. Fairhurst; Annette Bayer; Bengt Erik Haug (2016). Synthesis of Analogues of the Bioactive Compound Barettin. (ekstern lenke)
• Rianne Harmsen; Leiv Kristen Sydnes; Bengt Erik Haug (2011). Synthesis of 3,4-disubstituted piperidines. (ekstern lenke)

Arbeidsnotat

• Hans-Rene Bjørsvik; Leiv Kristen Sydnes; Bengt Erik Haug (2010). IUPAC ICOS-18 Proceedings. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Bengt Erik Haug; Morten B. Strøm; John Sigurd Svendsen (2007). The medicinal chemistry of short lactoferricin-based antibacterial peptides. (ekstern lenke)
• Jon Våbenø; Bengt Erik Haug; Mette M. Rosenkilde (2015). Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists. (ekstern lenke)

Doktorgradsavhandling

• Rianne Harmsen; Bengt Erik Haug; Leiv Kristen Sydnes (2012). Synthesis of novel renin inhibitors. (ekstern lenke)
• Tahir Farooq; Bengt Erik Haug; Leiv Kristen Sydnes (2012). Synthesis of Some Nitrogen Heterocycles of Medicinal Relevance. (ekstern lenke)
• Markus Baumann; Bengt Erik Haug; Jon Våbenø (2016). Synthesis of Bicyclic CXCR4 Antagonists. (ekstern lenke)
• Adnan Budnjo; Bengt Erik Haug (2014). Synthesis of serine protease inhibitors. (ekstern lenke)

Fremhevet artikkel i media

• Annette Bayer; Bengt Erik Haug; Bård Helge Hoff et al. (2024). Kjemi og beredskap. (ekstern lenke)
• Annette Bayer; Bengt Erik Haug; Bård Helge Hoff et al. (2024). Kjemi og legemiddelberedskap. (ekstern lenke)

Populærvitenskapelig artikkel

• Tore Sigvard Lejon; Bengt Erik Haug (2001). FARGESTOFFER I SOPP. (ekstern lenke)

Konferanseabstrakt

• Zack Georg Zachariassen; S Thiele; MM Rosenkilde et al. (2011). SAR and Binding Mode for CXCR4 Antagonists Based on an Arg-Arg-Nal Tripeptide Motif. (ekstern lenke)
• Rianne Harmsen; A Sivertsen; Davide Michetti et al. (2012). Synthesis and docking of 4-triazolyl substituted piperidine derivatives as novel renin inhibitors. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.